Potential Use of Cellular Stromal Vascular Fraction In Post-COVID-19 Pulmonary Injury and Adult Respiratory Distress Syndrome: Overview of COVID-19 Lung …

RW Alexander - Journal of Current Medical Research and Opinion, 2020 - cmro.in
Abstract A coronavirus (nCoV-2) has caused a worldwide pandemic, beginning in Wuhan,
China. Patient's acquiring viral infection (COVID-19) which is often featured by elevation of …

[PDF][PDF] Overview of COVID-19 lung damage clinical trial using Cellular Stromal Vascular Fraction (CSVF) and Functional Respiratory Imaging (FRI) analysis of …

RW Alexander - Ann. Stem Cell Res. Ther, 2020 - nkjinstitute.com
Abstract A coronavirus (nCoV-2) has caused a worldwide pandemic, beginning in Wuhan,
China. Patient's acquiring viral infection (COVID-19) which is featured by elevation of …

Therapeutic potential of the stromal vascular fraction in COVID-19

VN Pavlov, AA Kazikhinurov… - HERALD of North …, 2021 - journals.eco-vector.com
The new coronavirus infection (COVID-19) is already known to cause serious respiratory
illnesses such as pneumonia and lung failure. COVID-19 has caused catastrophic damage …

[HTML][HTML] Adipose stem cells (ASCs) and stromal vascular fraction (SVF) as a potential therapy in combating (COVID-19)-disease

P Gentile, A Sterodimas - Aging and disease, 2020 - ncbi.nlm.nih.gov
A recent and interesting study reported improved respiratory activity after intravenous
administration of mesenchymal stem cells (MSCs) into patients affected by coronavirus …

[HTML][HTML] Adipose-derived stromal vascular fraction cells to treat long-term pulmonary sequelae of coronavirus disease 2019: 12-month follow-up

M Carstens, J Trujillo, Y Dolmus, C Rivera… - Cytotherapy, 2024 - Elsevier
Background aims Long coronavirus disease (COVID) is estimated to occur in up to 20% of
patients with coronavirus disease 2019 (COVID-19) infections, with many having persistent …

Total Stromal Fraction (TSF)-Fortified Adipose Tissue-Derived Stem Cells Source: An Emerging Regenerative Realm Against COVID-19 Induced Pulmonary …

M Jeyaraman, S Muthu, R Jain, AS Satish… - …, 2022 - ingentaconnect.com
The inception of the COVID-19 pandemic has jeopardized humanity with markedly
dampening of worldwide resources. The viral infection may present with varying signs and …

[HTML][HTML] Therapeutic prospects of mesenchymal stem/stromal cells in COVID-19 associated pulmonary diseases: From bench to bedside

LS Zhang, Y Yu, H Yu, ZC Han - World Journal of Stem Cells, 2021 - ncbi.nlm.nih.gov
The ongoing outbreak of coronavirus disease 2019 (COVID-19) caused by the novel severe
acute respiratory syndrome coronavirus 2 has become a sudden public emergency of …

Post-COVID-19 pulmonary fibrosis: the rationale of mesenchymal stem cell transplantation for lung regeneration

NNQ Dinh, NB Vu, P Van Pham - Biomedical Research and Therapy, 2022 - bmrat.com
Abstract Coronavirus disease 2019 (COVID-19) has caused nearly 15 million deaths
worldwide. The rapid development of COVID-19 vaccines and anti-viral drugs significantly …

Mesenchymal stromal cells and pleiotropic therapeutic advantages in COVID-19 management

VK Singh, UKS Vaksh, P Sharma - Stem Cells, 2024 - Elsevier
The pandemic burst of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or
coronavirus disease 2019 (COVID-19) infections shattered existing medical and research …

Potential application of mesenchymal stromal cells as a new therapeutic approach in acute respiratory distress syndrome and pulmonary fibrosis

G Gazzaniga, M Voltini, A Carletti, E Lenta… - Respiratory …, 2024 - Springer
While the COVID-19 outbreak and its complications are still under investigation, post-
inflammatory pulmonary fibrosis (PF) has already been described as a long-term sequela of …